title: Treatment of neuropathic pain in patients with chronic kidney disease.
authors.affiliation: Manitoba Renal Program, Winnipeg Regional Health Authority, Winnipeg, MB. hnaylor@sogh.mb.ca
authors.forename: Heather K
authors.initials: HK
authors.lastname: Naylor
authors.forename: Colette B
authors.initials: CB
authors.lastname: Raymond
mesh_terms: D000588:Amines / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000150:complications / Q000628:therapy; D000077206:Gabapentin; D006801:Humans; D009437:Neuralgia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D000069583:Pregabalin; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D000069470:Venlafaxine Hydrochloride; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000588:Amines; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D003509:Cyclohexanecarboxylic Acids; D003511:Cyclohexanols; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000069470:Venlafaxine Hydrochloride